Teradyne

US · TER #391 by market cap Listed 1970

411.78 -18.54 -4.31%

Live - 5344 symbols - heartbeat 84s ago · 2026-10-08 07:00

Pre-market 401.50 -2.50%

After-hours 414.70 +0.71%

Overnight 405.50 -1.53%

Market cap: 64.38B
P/E (TTM): 56.56
P/B: 18.73
EPS: 3.47
Div yield: 0.12%
52W pos: 78%

Reader sentiment Are you bullish or bearish on TER?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 29.63, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +13.13% YoY

Margins

Gross margin: 58.22%
Operating margin: 21.59%
Net margin: 17.37%

Key ratios & quality

Altman Z-Score: 29.63

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.10B	2.29B	3.12B	3.70B	3.16B	2.68B	2.82B	3.19B
Gross profit	1.22B	1.34B	1.79B	2.21B	1.87B	1.54B	1.65B	1.86B
Selling & admin expenses	390.67M	437.08M	464.77M	547.56M	558.10M	577.32M	617.05M	648.87M
Research & development	301.51M	322.82M	374.96M	427.61M	440.59M	418.09M	460.88M	504.60M
Operating profit	489.03M	539.77M	915.21M	1.21B	849.12M	522.35M	552.24M	688.61M
Pretax profit	467.80M	525.77M	901.02M	1.16B	840.39M	525.57M	609.09M	653.26M
Tax	16.02M	58.30M	116.87M	146.37M	124.88M	76.82M	59.50M	79.30M
Net profit	451.78M	467.47M	784.15M	1.01B	715.50M	448.75M	542.37M	554.05M
Basic EPS	2	3	5	6	5	3	3	3
Diluted EPS	2.35	2.60	4.28	5.53	4.22	2.73	3.32	3.47

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	685.68M	651.80M	769.21M	1.08B	1.28B	1.33B
Gross profit	415.34M	373.01M	449.31M	619.69M	780.95M	794.62M
Selling & admin expenses	157.26M	157.78M	169.14M	164.69M	166.74M	192.52M
Research & development	118.19M	118.38M	124.76M	143.27M	135.56M	156.28M
Operating profit	135.32M	93.12M	151.89M	308.28M	476.43M	440.84M
Pretax profit	119.02M	96.56M	148.10M	289.58M	465.68M	443.62M
Tax	14.54M	12.26M	23.34M	29.15M	62.16M	66.79M
Net profit	98.90M	78.37M	119.56M	257.22M	398.91M	374.89M
Basic EPS	1	0	1	2	3	2
Diluted EPS	0.61	0.49	0.75	1.63	2.53	2.38

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.73B	1.66B	2.42B	2.58B	2.26B	2.16B	1.82B	1.95B
Cash & ST investments	1.12B	911.23M	1.44B	1.37B	894.39M	819.73M	599.67M	322.00M
Inventory	153.54M	196.69M	222.19M	243.33M	325.02M	309.97M	298.49M	379.55M
Total assets	2.71B	2.79B	3.65B	3.81B	3.50B	3.49B	3.71B	4.18B
Total current liabilities	476.29M	539.03M	700.87M	805.12M	746.26M	659.95M	624.58M	1.12B
Short-term debt	--	19.48M	53.92M	39.16M	68.71M	17.52M	18.70M	219.34M
Long-term debt	379.98M	394.69M	376.77M	89.24M	--	--	--	--
Total liabilities	1,184,252,000.00	1,306,856,000.00	1,441,541,000.00	1,245,469,000.00	1,049,958,000.00	960,927,000.00	889,420,000.00	1,387,847,000.00
Total equity	1.52B	1.48B	2.21B	2.56B	2.45B	2.53B	2.82B	2.80B
Retained earnings	-158.19M	-241.92M	387.41M	736.57M	725.73M	706.51M	970.76M	744.44M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	1.76B	1.58B	1.75B	1.95B	2.17B	2.37B
Cash & ST investments	507.78M	367.89M	297.72M	322.00M	245.60M	354.83M
Inventory	345.06M	350.51M	366.75M	379.55M	362.76M	403.30M
Total assets	3.71B	3.76B	3.96B	4.18B	4.43B	4.93B
Total current liabilities	649.07M	675.27M	994.99M	1.12B	1.01B	1.11B
Short-term debt	18.34M	19.77M	19.03M	219.34M	18.44M	17.26M
Long-term debt	--	--	--	--	--	--
Total liabilities	908,338,000.00	924,561,000.00	1,246,456,000.00	1,387,847,000.00	1,290,011,000.00	1,452,304,000.00
Total equity	2.80B	2.84B	2.72B	2.80B	3.14B	3.47B
Retained earnings	893.23M	834.86M	686.78M	744.44M	1.12B	1.40B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	476.88M	578.75M	868.94M	1.10B	577.92M	585.23M	672.18M	674.42M
Depreciation & amortization	113.22M	120.66M	126.74M	125.49M	110.68M	110.89M	119.74M	127.98M
Free cash flow	362.50M	444.11M	683.96M	965.89M	414.67M	425.59M	474.08M	450.41M
Dividends paid	-67.32M	-61.31M	-66.48M	-65.98M	-69.71M	-67.88M	-76.42M	-76.31M
Stock buybacks / issuance	-823.48M	-500.00M	-88.47M	-600.00M	-752.08M	-397.24M	-198.57M	-702.10M
Ending cash balance	926.75M	773.92M	914.12M	1.12B	854.77M	757.57M	553.35M	293.75M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	161.64M	182.09M	49.05M	281.64M	265.12M	469.14M
Depreciation & amortization	30.30M	31.39M	30.52M	35.77M	32.66M	33.65M
Free cash flow	97.62M	131.68M	2.36M	218.75M	200.39M	378.43M
Dividends paid	-19.41M	-19.18M	-18.99M	-18.74M	-20.36M	-20.35M
Stock buybacks / issuance	-157.48M	-117.40M	-243.79M	-183.44M	-5.52M	-68.72M
Ending cash balance	475.63M	339.25M	272.70M	293.75M	241.94M	349.54M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	25.99	31.14	42.49	42.50	28.53	18.03	20.29	19.73
ROA %	15.54	17.02	24.35	27.19	19.57	12.84	15.08	14.04
ROIC %	21.61	24.13	34.60	37.84	26.75	16.51	19.01	18.29
5-year avg ROE %	10.31	15.74	22.19	31.15	34.13	32.54	30.37	25.82
EBIT margin %	23.76	23.92	29.64	31.83	26.75	19.78	21.73	20.69
FCF / sales %	17.26	19.35	21.91	26.08	13.14	15.90	16.81	14.12
Current ratio	3.64	3.08	3.45	3.20	3.03	3.28	2.91	1.75
Quick ratio	2.96	2.36	2.76	2.38	1.86	1.88	1.71	0.99
Debt / assets	14.04	16.51	12.94	4.85	3.80	2.37	2.07	6.77
LT debt / equity	24.96	29.76	18.95	5.67	2.62	2.58	2.05	2.29
Interest coverage	15.96	23.72	38.26	66.15	226.97	139.09	170.80	96.42
Revenue CAGR (3Y) %	8.61	9.39	13.47	20.80	11.19	-5.00	-8.68	0.37
Net income CAGR (3Y) %	29.82	--	44.91	30.95	15.24	-16.98	-18.84	-8.17
FCF CAGR (3Y) %	2.85	6.28	9.49	38.64	-2.26	-14.63	-21.12	2.79

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	21.55	16.85	15.77	19.73	28.75	36.66
ROA %	16.22	12.69	11.46	14.04	20.99	26.48
ROIC %	20.36	15.86	14.92	18.29	27.93	35.66
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	22.68	18.93	18.36	20.69	26.65	30.43
FCF / sales %	20.94	20.12	15.98	14.12	14.61	17.92
Current ratio	2.70	2.35	1.76	1.75	2.15	2.12
Quick ratio	1.49	1.19	0.90	0.99	1.34	1.32
Debt / assets	1.86	1.98	1.73	6.77	1.86	2.03
LT debt / equity	1.80	1.93	1.83	2.29	2.03	2.41
Interest coverage	177.08	178.63	150.08	96.42	109.66	119.56
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Semiconductor Test is the largest reported line at 84.41% of revenue, across 3 reported segments.
The next-largest line, Product Test, is a distant second at 8.07% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Semiconductor Test84.41%

Product Test8.07%

Robotics7.52%

Quote time 2026-10-08 07:00:14 · For reference only, not investment advice and not tailored to your situation.